The National Cancer Institute (NCI) awarded a $5,151,564 Project Grant (CFDA 93.397 - Cancer Centers Support Grants) to the Fred Hutchinson Cancer Center (doing business as the Seattle Cancer Care Alliance) to establish a Translational Research Program in Colorectal Cancer Disparities. This 5-year program aims to reduce persistent racial and ethnic disparities in colorectal cancer incidence, mortality, and outcomes, with a focus on Alaska Native and African American populations.
The program will conduct four translational research projects supported by administrative, biospecimen, and biostatistics/bioinformatics cores. Key activities include: 1) developing risk prediction models to improve screening and early detection across diverse populations; 2) discovering and validating novel molecular and biological factors related to lethal colorectal cancer risk and treatment response in racially/ethnically diverse patients; and 3) identifying new therapeutic targets and testing interventions to reduce disparities. The program leverages a large, diverse biorepository and genomic dataset to drive these translational research objectives. Sub-awards to the University of Washington, Cedars-Sinai Medical Center, University of California San Francisco, Alaska Native Tribal Health Consortium, and Ochsner Clinic Foundation will contribute specialized expertise, data, and biospecimens to support the overall research aims.
Generated 3/18/25, 4:01 AM